A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against Helicobacter pylori

Helicobacter pylori is responsible for a wide range of gastric diseases, including gastric cancer and gastritis. With half of the world’s population infected by H. pylori and the current standard of care associated with suboptimal outcomes, a search for more effective drugs is critical. To facilitat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Abdolhakim, Chilingerian, John N, Bali, Prerna, Obonyo, Marygorret, Debnath, Anjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686901/
https://www.ncbi.nlm.nih.gov/pubmed/36421252
http://dx.doi.org/10.3390/antibiotics11111605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686901/
https://www.ncbi.nlm.nih.gov/pubmed/36421252
http://dx.doi.org/10.3390/antibiotics11111605

Ejemplares similares